BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29857096)

  • 1. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
    Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
    Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
    Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
    J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous.
    Manna S; Donnell AM; Faraj RQC; Riemann BI; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
    Manna S; Caixeta Faraj RQ; Riemann B; Rao MB; Nair V; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
    Exp Eye Res; 2021 Apr; 205():108505. PubMed ID: 33617850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP
    Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
    Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
    Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
    Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
    Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Superparamagnetic Microdevices Based on Magnetized PLGA/PLA Microparticles Obtained by Supercritical Fluid Emulsion and Coating by Carboxybetaine-Functionalized Chitosan Allowing the Tuneable Release of Therapeutics.
    Cricchio V; Best M; Reverchon E; Maffulli N; Phillips G; Santin M; Della Porta G
    J Pharm Sci; 2017 Aug; 106(8):2097-2105. PubMed ID: 28499877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.
    Della Porta G; Campardelli R; Cricchio V; Oliva F; Maffulli N; Reverchon E
    J Pharm Sci; 2016 Jul; 105(7):2164-72. PubMed ID: 27290629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
    Ray S; Saha S; Sa B; Chakraborty J
    Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Correa ZM
    Exp Eye Res; 2016 Jul; 148():30-32. PubMed ID: 27181224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of poly(lactic acid-co-glycolic acid) complex microspheres as drug carriers.
    Wang F; Liu X; Yuan J; Yang S; Li Y; Gao Q
    J Biomater Appl; 2016 Oct; 31(4):544-552. PubMed ID: 27368752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2008 Jan; 346(1-2):151-9. PubMed ID: 17681683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.